Alzheimer’s drug lecanemab receives accelerated approval amid safety concerns – CNN

Food and Drug Administration of the United States granted accelerated approval Friday, Alzheimer’s Maladies drug lecanemabOne of the first drugs for dementia to show signs of slowing cognitive decline is ‘Alterative Care For Alzheimer’.